Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A4HAK4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.415 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.409 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.395 |
CLV_NRD_NRD_1 | 94 | 96 | PF00675 | 0.553 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.413 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.395 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.555 |
CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.542 |
CLV_PCSK_PC1ET2_1 | 87 | 89 | PF00082 | 0.600 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.583 |
DEG_APCC_DBOX_1 | 34 | 42 | PF00400 | 0.583 |
DOC_CDC14_PxL_1 | 58 | 66 | PF14671 | 0.351 |
DOC_MAPK_gen_1 | 35 | 43 | PF00069 | 0.672 |
DOC_PP4_FxxP_1 | 59 | 62 | PF00568 | 0.277 |
LIG_BRCT_BRCA1_1 | 55 | 59 | PF00533 | 0.333 |
LIG_CSL_BTD_1 | 59 | 62 | PF09270 | 0.277 |
LIG_FHA_2 | 104 | 110 | PF00498 | 0.385 |
LIG_LIR_Apic_2 | 56 | 62 | PF02991 | 0.356 |
LIG_LIR_Gen_1 | 48 | 57 | PF02991 | 0.277 |
LIG_LIR_Gen_1 | 72 | 83 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 48 | 52 | PF02991 | 0.277 |
LIG_LIR_Nem_3 | 56 | 61 | PF02991 | 0.277 |
LIG_LIR_Nem_3 | 72 | 78 | PF02991 | 0.298 |
LIG_MLH1_MIPbox_1 | 55 | 59 | PF16413 | 0.356 |
LIG_Pex14_1 | 53 | 57 | PF04695 | 0.296 |
LIG_SH2_CRK | 75 | 79 | PF00017 | 0.359 |
LIG_SH2_STAP1 | 55 | 59 | PF00017 | 0.277 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.277 |
LIG_SH3_3 | 23 | 29 | PF00018 | 0.653 |
LIG_WRC_WIRS_1 | 70 | 75 | PF05994 | 0.386 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.390 |
MOD_CK2_1 | 27 | 33 | PF00069 | 0.681 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.658 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.411 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.346 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.706 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.715 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.364 |
MOD_NEK2_2 | 53 | 58 | PF00069 | 0.367 |
MOD_NEK2_2 | 6 | 11 | PF00069 | 0.704 |
MOD_PIKK_1 | 99 | 105 | PF00454 | 0.466 |
MOD_Plk_1 | 108 | 114 | PF00069 | 0.365 |
MOD_Plk_1 | 97 | 103 | PF00069 | 0.377 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.649 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.516 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.298 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.367 |
MOD_SUMO_rev_2 | 16 | 26 | PF00179 | 0.653 |
MOD_SUMO_rev_2 | 86 | 93 | PF00179 | 0.341 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.280 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.270 |
TRG_ER_diArg_1 | 10 | 12 | PF00400 | 0.609 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.612 |
TRG_ER_diArg_1 | 93 | 95 | PF00400 | 0.352 |
TRG_Pf-PMV_PEXEL_1 | 95 | 99 | PF00026 | 0.586 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JM59 | Bodo saltans | 53% | 100% |
A0A1X0PAL9 | Trypanosomatidae | 59% | 100% |
A0A3Q8IUG3 | Leishmania donovani | 97% | 72% |
A0A3R7MBG9 | Trypanosoma rangeli | 66% | 100% |
A4I9P8 | Leishmania infantum | 96% | 72% |
C6K3V2 | Leptomonas seymouri | 90% | 100% |
C9ZMZ1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
E9B4R2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 72% |
Q4Q3B4 | Leishmania major | 96% | 100% |